Articles from Promise
Promise Clarifies NAD+ Classification Amid Federal Peptide Policy Review
The Scottsdale telehealth provider outlines the distinction between NAD+ and peptides, the status of compounded medications, and the role of individual prescriber review
By Promise · Via ACCESS Newswire · November 4, 2026